Preventive Cardiology
Dr. Kohli highlights the benefits of early, sustained LDL lowering for greater cardiovascular risk reduction and prevention.
High blood pressure and BMI will drive the global CVD burden through 2050, despite declines in age-standardized DALY rates.
New AHA risk tool may underestimate heart disease in some groups, highlighting need for more accurate, equitable prediction.
Heart risk factors like high LDL and belly fat may weaken brain memory networks, new Alzheimer’s study finds.
Non-statin therapies key for high-risk patients not at LDL goal, says Dr. Kohli; advocates broader risk assessment.
Survival after OHCA has improved over 20 years, driven by more bystander CPR and early defibrillator use.
Poor sleep predicts long-term heart risks in menopausal women, study shows—reinforcing sleep as a key health metric.
AHA says alcohol’s heart effects are complex, warns against heavy use, and urges more rigorous, unbiased research.
Women with lower perceived social status show early signs of heart stress, a risk not seen in men, new research finds.
AI is transforming cardiac imaging with faster diagnoses, better accuracy, and new insights into disease prediction.
Dual PET/MR imaging enables precise diagnosis and cardiac risk assessment in patients with primary aldosteronism.
Poor cardiovascular health before pregnancy may raise risk for both gestational diabetes and future cardiovascular disease.
Living near microplastic-polluted oceans linked to higher rates of diabetes, heart disease, and stroke, new study finds.
Higher cardiac biomarker levels predict greater future cancer risk.
A large review links cannabis use to higher risks of heart attack, stroke, and cardiovascular death.
AI-powered cardiac MRI shows how aging impacts heart structure—and reveals hidden risks from common conditions.
The ONSET/OFFSET and RESPOND trials are under scrutiny for overstated efficacy, per the BMJ report.
CKM syndrome redefines heart disease risk—90% of adults may already be affected. Learn why this new staging system matters.
Genomics and biomarkers can uncover hidden cardiac risk—enabling more personalized, life-saving heart disease prevention.
The researchers successfully generated vascularized organoids that are scalable and reproducible.
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.